Europe - Frankfurt Stock Exchange - FRA:ZEG - GB0009895292 - Common Stock
Taking everything into account, ZEG scores 5 out of 10 in our fundamental rating. ZEG was compared to 54 industry peers in the Pharmaceuticals industry. While ZEG has a great profitability rating, there are some minor concerns on its financial health. While showing a medium growth rate, ZEG is valued expensive at the moment.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.21% | ||
| ROE | 20.48% | ||
| ROIC | 14.42% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 24.34% | ||
| PM (TTM) | 16.17% | ||
| GM | 81.9% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 3.41 | ||
| Altman-Z | 5.96 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.88 | ||
| Quick Ratio | 0.69 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.13 | ||
| Fwd PE | 17.67 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 59.56 | ||
| EV/EBITDA | 28.45 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.74% |
ChartMill assigns a fundamental rating of 5 / 10 to ZEG.DE.
ChartMill assigns a valuation rating of 3 / 10 to ASTRAZENECA PLC (ZEG.DE). This can be considered as Overvalued.
ASTRAZENECA PLC (ZEG.DE) has a profitability rating of 7 / 10.
The Price/Earnings (PE) ratio for ASTRAZENECA PLC (ZEG.DE) is 20.13 and the Price/Book (PB) ratio is 12.42.
The Earnings per Share (EPS) of ASTRAZENECA PLC (ZEG.DE) is expected to grow by 11.95% in the next year.